Volume 7, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
Sophie Croizier, Vincent Prevot, Sebastien G. Bouret  Cell Reports 
Advertisements

Volume 4, Issue 12, Pages (December 2015)
Volume 9, Issue 3, Pages (March 2009)
Volume 1, Issue 2, Pages (February 2005)
Volume 11, Issue 8, Pages (May 2015)
Volume 10, Issue 4, Pages (February 2015)
Volume 20, Issue 10, Pages (September 2017)
Volume 17, Issue 3, Pages (October 2016)
Volume 3, Issue 5, Pages (May 2006)
Volume 16, Issue 10, Pages (September 2016)
Volume 23, Issue 5, Pages (May 2018)
Volume 14, Issue 12, Pages (March 2016)
Volume 24, Issue 6, Pages (December 2016)
Volume 22, Issue 4, Pages (October 2015)
Volume 10, Issue 4, Pages (October 2009)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 23, Issue 7, Pages (May 2018)
Volume 6, Issue 3, Pages (September 2007)
Volume 59, Issue 3, Pages (August 2015)
Volume 18, Issue 1, Pages (July 2013)
Volume 23, Issue 5, Pages (May 2016)
Volume 19, Issue 4, Pages (April 2014)
Volume 10, Issue 4, Pages (February 2015)
Volume 128, Issue 5, Pages (May 2005)
Volume 21, Issue 11, Pages (December 2017)
Volume 26, Issue 5, Pages e3 (November 2017)
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 17, Issue 5, Pages (May 2013)
Volume 134, Issue 3, Pages (March 2008)
Volume 15, Issue 5, Pages (May 2012)
Volume 22, Issue 4, Pages (January 2018)
Volume 25, Issue 2, Pages (February 2017)
Volume 22, Issue 10, Pages (March 2018)
Volume 66, Issue 3, Pages e4 (May 2017)
Volume 12, Issue 3, Pages (July 2015)
Volume 14, Issue 12, Pages (March 2016)
Volume 18, Issue 13, Pages (March 2017)
Characterization of Glucose Transport System in Keratinocytes: Insulin and IGF-1 Differentially Affect Specific Transporters  Shlomzion Shen, Sanford.
Volume 25, Issue 6, Pages e8 (June 2017)
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
Volume 16, Issue 7, Pages (August 2016)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 16, Issue 4, Pages (October 2012)
Volume 9, Issue 5, Pages (May 2009)
Volume 17, Issue 8, Pages (November 2016)
Volume 103, Issue 11, Pages (December 2012)
Volume 14, Issue 7, Pages (February 2016)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 6, Issue 3, Pages (September 2007)
Blocking Ca2+ Channel β3 Subunit Reverses Diabetes
Volume 13, Issue 12, Pages (December 2015)
Volume 7, Issue 5, Pages (June 2014)
Volume 8, Issue 5, Pages (November 2008)
Volume 17, Issue 3, Pages (October 2016)
Volume 24, Issue 6, Pages e4 (June 2017)
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 22, Issue 4, Pages (October 2015)
Volume 12, Issue 1, Pages (July 2015)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, Helena Edlund 
Insulin resistance and hepatic steatosis in ASKO mice.
Volume 24, Issue 1, Pages (July 2018)
Volume 20, Issue 6, Pages (December 2014)
Volume 24, Issue 6, Pages (December 2016)
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Presentation transcript:

Volume 7, Issue 6, Pages 2042-2053 (June 2014) Mitochondrial Pyruvate Carrier 2 Hypomorphism in Mice Leads to Defects in Glucose- Stimulated Insulin Secretion  Patrick A. Vigueira, Kyle S. McCommis, George G. Schweitzer, Maria S. Remedi, Kari T. Chambers, Xiaorong Fu, William G. McDonald, Serena L. Cole, Jerry R. Colca, Rolf F. Kletzien, Shawn C. Burgess, Brian N. Finck  Cell Reports  Volume 7, Issue 6, Pages 2042-2053 (June 2014) DOI: 10.1016/j.celrep.2014.05.017 Copyright © 2014 The Authors Terms and Conditions

Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 1 MPC Proteins Are Highly Expressed in Tissues with High Mitochondrial Content (A) The schematic depicts an overview of mitochondrial pyruvate metabolism. OMM, outer mitochondrial membrane; IMM, inner mitochondrial membrane; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase; OAA, oxaloacetate; TCA, tricarboxylic acid. (B) Western blot depicting expression of the indicated proteins in whole-cell lysates from various C57Bl/6 mouse tissues. Cytochrome c (cyto c) is shown to demonstrate mitochondrial abundance in the whole-cell lysates. (C) Quantified densitometry of the western blot shown in (B). Data are presented as mean ± SEM (n = 3 separate animals). (D) Expression pattern of Mpc1 and Mpc2 in C57Bl/6 mice as measured by qRT-PCR. Values are expressed as arbitrary units (AU) and presented as mean ± SEM (n = 5 separate animals). Br, brain; BAT, brown adipose tissue; Epi, epididymal adipose tissue; PR, perirenal adipose tissue; Gas, gastrocnemius; Sol, soleus; H, heart; Int, intestine; Kid, kidney; Liv, liver; Lu, lung; Spl, spleen. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 2 Generation of MPC2-Deficient Mice (A) Western blot depicting the abundance of MPC1, MPC2, PC, and PDH complex protein in mitochondrial lysates of various tissues from Mpc2Δ16 mice and WT controls. VDAC1 is used as a loading control. (B) The ability of WT MPC2 and MPC2Δ16 protein to coimmunoprecipitate MPC1 was tested by using an antibody against the C terminus of MPC2 and BAT mitochondrial lysates from WT and Mpc2Δ16 mice. Negative control (irrelevant immunoglobulin G [IgG]) and input (nonprecipitated mitochondrial lysates) are also shown for comparison. (C) Western blots for MPC1 and MPC2 after subcellular fractionation to separate cytosolic and mitochondrial fractions from WT and Mpc2Δ16 mice are shown. LDH is used to demarcate the cytosolic fraction, and VDAC1 demarcates the mitochondrial fraction. (D) Western blots after mitochondrial subfractionation to separate cytosolic, OMM, IMM, and matrix components by using liver from WT and Mpc2Δ16 mice. LDH demarcates the cytosolic fraction, cytochrome c oxidase subunit 4 (Cox4) demarcates the IMM, and PC demarcates the matrix. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 3 Mpc2Δ16 Mice Have a Diminished Capacity for Pyruvate Utilization, but Exercise Capacity Is Unimpaired (A) DNP-stimulated rates of oxygen consumption by mitochondria isolated from heart or kidney of WT or Mpc2Δ16 mice in the presence of the indicated substrates (n = 8). (B) TMRE staining of tail fibroblasts isolated from WT or Mpc2Δ16 mice (n = 8, separate experiments in duplicate). (C) Schematic of the exercise protocol. Shown are blood glucose and blood lactate curves for WT, Mpc2+/−, and Mpc2Δ16 mice following graduated-intensity exercise on a motor-driven treadmill (n = 6), and elapsed time until exhaustion for WT, Mpc2+/−, and Mpc2Δ16 mice during graduated-intensity exercise (n = 6). Data are presented as mean ± SEM. ∗p < 0.05, Mpc2Δ16 versus WT. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 4 Mpc2Δ16 Mice Have Elevated Blood Glucose and Blood Lactate during a PTT, but Gluconeogenesis Remains Unimpaired (A) Blood glucose and blood lactate curves for WT, Mpc2+/−, and Mpc2Δ16 mice during i.p. PTT (n = 14). (B) 13C enrichment of plasma glucose isotopomers and total 13C-labeled plasma glucose. (C) 13C enrichment of plasma lactate isotopomers and total 13C-labeled plasma lactate (n = 7). (D) Expression of liver gluconeogenesis enzymes. (E) Plasma insulin 15 min after bolus pyruvate injection. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01 Mpc2Δ16 versus WT. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 5 Mpc2Δ16 Mice Are Responsive to Insulin, but Are Glucose Intolerant and Hypoinsulinemic (A) Blood glucose and blood lactate curves for WT and Mpc2Δ16 mice during i.p. ITT (n = 14). Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01 Mpc2Δ16 versus WT. (B) Western blot and quantified densitometry of liver S473-AKT phosphorylation 15 min after insulin injection. (C) Western blot and quantified densitometry of gastrocnemius S473-AKT phosphorylation 15 min after insulin injection. (D) Blood glucose and blood lactate curves for WT and Mpc2Δ16 mice during an i.p. GTT (n = 15). (E) Plasma insulin from blood collected during an i.p. glucose challenge (n = 9). Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01 Mpc2Δ16 versus WT. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions

Figure 6 Elevated Blood Glucose and Defective GSIS in Mpc2Δ16 Mice Are Corrected by Glibenclamide Treatment (A) Images from immunofluorescent staining of pancreatic islets from C57Bl/6 mice with antibodies against MPC1 (green), MPC2 (green), or insulin (red) are shown. (B) Western blot depicting the abundance of MPC2 and MPC1 protein using protein lysates from isolated islets from Mpc2Δ16 mice and WT controls. (C) Insulin content of islets isolated from WT and Mpc2Δ16 mice (n = 6). (D) Insulin secretion by isolated pancreatic islets from WT and Mpc2Δ16 mice in response to the indicated stimuli (n = 6). (E) Blood glucose and blood lactate curves during an i.p. GTT for WT and Mpc2Δ16 mice treated with glibenclamide or saline vehicle (n = 11–13). (F) Plasma insulin from blood collected during the experiment described in (E) (n = 11–13). Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01 Mpc2Δ16 versus WT. Cell Reports 2014 7, 2042-2053DOI: (10.1016/j.celrep.2014.05.017) Copyright © 2014 The Authors Terms and Conditions